Abstract Purpose of Review In recent years, the spectrum of neurological manifestations of
antiphospholipid syndrome (APS) has been growing. We provide a critical review of the …

Anti-β-2 glycoprotein I antibodies (anti-B2GPI) are often cited as the major pathogenically
relevant antibody in antiphospholipid syndrome (APS), but it is unclear if there is clinical …

Background: Ischemic stroke is the most common and severe arterial thrombotic event in
Antiphospholipid syndrome (APS). APS is an autoimmune disease characterized by the …

Anti‐phospholipid syndrome (APS) recapitulates the link between autoimmunity and
pregnancy failure: Acquired anti‐phospholipid antibodies (aPL) play a pathogenic role in …

Antiphospholipid syndrome (APS) is a leading acquired cause of thrombotic events, with a
notable tendency to promote thrombosis in vascular beds of all sizes, including both arterial …

It is now widely accepted that antiphospholipid antibodies (aPL) have direct pathogenic
effects and that B cells, notably through aPL production, play a key role in the development …

Abstract Coronavirus 2019 disease (COVID-19) is associated with coagulation dysfunction
that predisposes patients to an increased risk for both arterial (ATE) and venous …

The pathogenesis of the antiphospholipid syndrome (APS) is complex and involves the
persistent presence of antiphospholipid antibodies (aPL) in the bloodstream causing a …

Background: Anti-phospholipid syndrome (APS) and systemic lupus erythematous (SLE) are
autoimmune disorders that often co-occur. Anti-phospholipid antibodies (aPL) are typical of …

Although considerable advances have been made in the field of assisted reproductive
technology (ART), millions of couples still suffer from infertility and miscarriage. In a large …